Paraneoplastic Hepatitis Associated with Relapsed Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Hematology Reports · 28.02.2026 · 18 (2) · 18
DOI: 10.3390/hematolrep18020018 ↗Kurz gefasst
Fallbericht in der Zeitschrift Hematology Reports, online erschienen am 28.02.2026. Verfasst von Jasmin Nelissen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is an indolent B-cell lymphoma with long-term survival and a tendency for late relapse. Hepatic manifestations of varying etiologies have been described in lymphoproliferative disorders. However, paraneoplastic hepatitis is rare, and reports typically describe acute presentations. We describe an unusual case of paraneoplastic hepatitis with an indolent and progressive clinical course occurring in the setting of relapsed NLPHL. Case Presentation: A 32-year-old man with a history of NLPHL was found to have marked transaminase elevation with preserved liver function during routine follow-up. Extensive evaluation excluded viral, autoimmune, and metabolic causes of liver disease. Liver biopsy demonstrated confluent and bridging necrosis with lymphoplasmacytic infiltrates, without evidence of direct lymphoma involvement. Excisional biopsy of a cervical lymph node revealed relapse of NLPHL without histologic transformation. Treatment with corticosteroids resulted in partial biochemical improvement, and subsequent rituximab monotherapy achieved lymphoma remission. Despite this, low-grade transaminase elevation persisted, and follow-up imaging and liver biopsy demonstrated progression to fibrosis, suggesting a tendency towards chronicity.
Conclusions
Paraneoplastic hepatitis should be considered in patients with NLPHL who present with unexplained liver abnormalities. This report illustrates a fibrosing form of paraneoplastic hepatitis associated with NLPHL and broadens the clinical spectrum of paraneoplastic hepatic injury. Early recognition, histological confirmation, and tailored immunosuppressive management are critical to optimizing hepatic and lymphoma-related outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.
- Department of Gastroenterology and Hepatology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.
- Department of Pathology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.
ORCID-Profile: Jasmin Nelissen, King Lam, Michael Doukas, Yasmina Serroukh
Zitieren
APA
Nelissen, J., Coenen, S., Lam, K., Doukas, M., Janssen, H. L. A., & Serroukh, Y. (2026). Paraneoplastic Hepatitis Associated with Relapsed Nodular Lymphocyte-Predominant Hodgkin Lymphoma. Hematology Reports, 18(2), 18. https://doi.org/10.3390/hematolrep18020018
Vancouver
Nelissen J, Coenen S, Lam K, Doukas M, Janssen HLA, Serroukh Y. Paraneoplastic Hepatitis Associated with Relapsed Nodular Lymphocyte-Predominant Hodgkin Lymphoma. Hematology Reports. 2026;18(2):18. doi:10.3390/hematolrep18020018
BibTeX
@article{Nelissen2026,
author = {Nelissen, Jasmin and Coenen, Sandra and Lam, King and Doukas, Michael and Janssen, Harry L A and Serroukh, Yasmina},
title = {Paraneoplastic Hepatitis Associated with Relapsed Nodular Lymphocyte-Predominant Hodgkin Lymphoma},
journal = {Hematology Reports},
year = {2026},
volume = {18},
number = {2},
pages = {18},
doi = {10.3390/hematolrep18020018}
}
EUVIMED